Pharmacology effect of neurogenic inflammation
| dc.contributor.advisor | Pórszász, Róbert | |
| dc.contributor.advisordept | Department of Pharmacology and Pharmacotherapy | hu_HU |
| dc.contributor.author | Matsuyama, Kyohhei | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
| dc.contributor.opponent | Drimba, László | |
| dc.contributor.opponent | Szentmiklósi, József András | |
| dc.contributor.opponentdept | Kenézy Kórház, Aneszteziológiai és Intenziv Therápiás Osztály | hu_HU |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.date.accessioned | 2022-01-19T12:24:59Z | |
| dc.date.available | 2022-01-19T12:24:59Z | |
| dc.date.created | 2021-11-05 | |
| dc.description.abstract | Inflammation is a common protective mechanism to remove initial cause of cell injury. In the nervous system, sensory nerves and leukocytes regulate inflammation by secretion of neuropeptides such as substance P and neurokinin A centrally and peripherally causing neurogenic inflammation. It causes several diseases in different organs: migraines, asthma, atopic dermatitis, and psoriasis. The pharmacology effect of neurogenic inflammation depends on the receptors located in the organs. A variety of drugs have now been developed and are effective against neurogenic inflammation. | hu_HU |
| dc.description.course | általános orvos | hu_HU |
| dc.description.courselang | angol | hu_HU |
| dc.description.degree | egységes, osztatlan | hu_HU |
| dc.format.extent | 35 | hu_HU |
| dc.identifier.uri | http://hdl.handle.net/2437/328036 | |
| dc.language.iso | en | hu_HU |
| dc.subject | neurogenic inflammation | hu_HU |
| dc.subject | migraine | hu_HU |
| dc.subject | CGRP receptors | hu_HU |
| dc.subject.dspace | DEENK Témalista::Orvostudomány | hu_HU |
| dc.title | Pharmacology effect of neurogenic inflammation | hu_HU |